4-n-butylresorcinol has been researched along with ginsenoside rb1 in 2 studies
| Studies (4-n-butylresorcinol) | Trials (4-n-butylresorcinol) | Recent Studies (post-2010) (4-n-butylresorcinol) | Studies (ginsenoside rb1) | Trials (ginsenoside rb1) | Recent Studies (post-2010) (ginsenoside rb1) |
|---|---|---|---|---|---|
| 23 | 7 | 19 | 568 | 3 | 382 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, SH; Manickam, M; Namasivayam, V; Pillaiyar, T | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 review(s) available for 4-n-butylresorcinol and ginsenoside rb1
| Article | Year |
|---|---|
Inhibitors of Melanogenesis: An Updated Review.
Topics: alpha-MSH; Biphenyl Compounds; Crystallization; Enzyme Inhibitors; Humans; Melanins; Monophenol Monooxygenase; Peptidomimetics; Radiation, Ionizing; Resveratrol; Signal Transduction; Skin | 2018 |
1 other study(ies) available for 4-n-butylresorcinol and ginsenoside rb1
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |